Sclerosing Retroperitoneal Fibrosis

Slide 1 · Sclerosing Retroperitoneal

Fibrosis

Fibroinflammation · Ureteral obstruction · IgG4-related subset

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define retroperitoneal fibrosis as an extrinsic fibroinflammatory cause of ureteral obstruction.

Distinguish idiopathic disease, IgG4-related disease, and recognized secondary associations.

Interpret its characteristic histology and explain the renal consequences of obstruction.

Relate disease biology to corticosteroids, urinary diversion, and ureterolysis.

Slide 3 · From retroperitoneal lesion to renal injury

Schematic causal sequence

1

Fibroinflammatory proliferation

2

Enclosure of retroperitoneal structures

3

Ureteral outflow obstruction

4

Hydroureter / hydronephrosis

Interpretation

The lesion lies outside the ureter, but the principal clinical consequence is within the urinary collecting system.

Slide 4 · Anatomic setting: The ureters are at risk

Conceptual urinary outflow anatomy

Fibrosis surrounding ureters

Fibrosis occupies retroperitoneal connective tissue.

The ureters traverse the retroperitoneal compartment.

Envelopment can compromise urinary drainage despite an extraluminal origin.

Slide 5 · Definition: A fibroinflammatory lesion

Characterized by proliferating fibrous tissue and accompanying inflammation.

Encloses retroperitoneal structures; Ureteral obstruction is a dominant consequence.

Clinically important because obstruction may culminate in hydronephrosis.

Clinicopathologic implication

The hallmark is an external sclerosing process, not a primary urothelial lesion.

Slide 6 · Extrinsic and intrinsic ureteral obstruction

Intrinsic

A lesion in the urinary tract lumen or wall blocks urine directly; Examples include calculi, strictures and ureteral carcinoma.

Extrinsic

A process outside the ureter presses on or envelops it; Retroperitoneal fibrosis is a classic inflammatory example.

Interpretation

The distinction directs attention to different anatomic sites and etiologic categories.

Slide 7 · Why an external plaque can obstruct both ureters

Conceptual urinary outflow anatomy

Fibrosis surrounding ureters

A retroperitoneal field of fibrosis may surround the ureteral paths.

Urinary collecting systems upstream of obstruction become dilated.

Bilateral involvement can threaten the function of both kidneys.

Slide 8 · Age and sex distribution

Disease principally in middle to late adulthood.

Males are affected more commonly than females.

This epidemiologic pattern overlaps with the profile of IgG4-related disease.

Clinicopathologic implication

A compatible demographic profile is contextual information, not a stand-alone diagnostic criterion.

Slide 9 · Etiologic framework

Schematic causal sequence

1

No evident cause: Idiopathic / Ormond disease

2

Immune-linked: IgG4-related subset

3

Associated exposures or inflammation

4

Malignancy-associated processes

Interpretation

The labels represent etiologic categories, not mutually exclusive microscopic patterns.

Slide 10 · Idiopathic disease: Ormond disease

Most cases have no obvious cause in the account given by Robbins.

These are designated primary or idiopathic retroperitoneal fibrosis.

Ormond disease is the traditional synonym used for this group.

Clinicopathologic implication

Idiopathic means that an etiology is not established; It does not prove absence of immune involvement.

Slide 11 · Idiopathic is not equivalent to IgG4-related

Idiopathic designation

An etiologic label used when the cause is not apparent after consideration of recognized associations.

IgG4-related designation

A clinicopathologic association with a systemic fibroinflammatory disease; It identifies at least a subset of cases.

Interpretation

Do not apply the IgG4 label to every case of idiopathic retroperitoneal fibrosis.

Slide 12 · IgG4-related retroperitoneal fibrosis

At least some cases form part of the IgG4-related disease spectrum.

IgG4-related disease produces lymphoplasmacytic inflammation and fibrosis across multiple organs.

IgG4-secreting plasma cells are often conspicuous in affected tissues.

Clinicopathologic implication

Retroperitoneal involvement is one manifestation of a wider immune-mediated fibroinflammatory disorder.

Slide 13 · IgG4-related disease is multiorgan

System / site

Robbins examples

Connection to this lecture

Pancreatobiliary

Autoimmune pancreatitis; sclerosing cholangitis

Distinct organs; shared fibroinflammatory spectrum

Head and neck

Salivary glands; thyroid; periorbital tissues

An extraretroperitoneal clue to systemic disease

Vascular / abdominal

Aorta; retroperitoneum

Periaortic and ureter-associated fibrosis

Other sites

Kidney, lung, meninges and others

Broad distribution, not a ureter-only condition

Organ examples illustrate the spectrum, not a diagnostic checklist.

Slide 14 · Drug-associated retroperitoneal fibrosis

Ergot derivatives are specifically mentioned among drug exposures.

β-Adrenergic blockers are another associated drug category.

A medication history is therefore relevant when considering secondary causes.

Clinicopathologic implication

The source lists associations; It does not specify exposure duration, incidence or causal strength.

Slide 15 · Inflammatory secondary associations

Associated condition

Disease group

Interpretive relevance

Vasculitis

Vascular inflammation

Consider a vascular/systemic inflammatory context

Diverticulitis

Gastrointestinal inflammation

A regional inflammatory process may coexist

Crohn disease

Chronic inflammatory bowel disease

An inflammatory history can inform etiologic assessment

These associations without defining their relative frequencies.

Slide 16 · Malignancy-associated retroperitoneal fibrosis

Association listed in Robbins

Important disease context

Lymphoma

A lymphoid malignancy may be associated with retroperitoneal fibroinflammatory change.

Urinary tract carcinoma

A carcinoma in the urinary system can create an alternative or associated obstructive process.

Other pelvic / retroperitoneal tumors

Table 21.1 includes multiple extrinsic tumor categories causing ureteral obstruction.

Fibrosis and obstruction do not, by themselves, exclude an underlying malignancy.

Slide 17 · Why the etiologic search matters

Schematic causal sequence

1

Identify fibroinflammatory obstruction

2

Check recognized exposures and inflammatory diseases

3

Consider associated malignancy

4

Interpret IgG4 features and systemic context

Interpretation

An etiologic category should follow evidence; A fibrotic appearance alone cannot settle the cause.

Slide 18 · Cause, association and mechanism are different claims

Several secondary associations but does not supply a single unifying cause.

IgG4-related disease is a recognized subset, not a synonym for all retroperitoneal fibrosis.

Similar obstructive consequences can arise from etiologically distinct processes.

Clinicopathologic implication

The lecture avoids converting reported associations into proven causal mechanisms.

Slide 19 · Macroscopic concept: Periureteral encasement

Conceptual urinary outflow anatomy

Fibrosis surrounding ureters

Dense fibroinflammatory material develops outside the ureter.

Circumferential involvement may impede the urine stream.

Upstream dilation is an effect of impaired outflow.

Slide 20 · Storiform fibrosis: A defining microscopic pattern

Schematic — not a histology image

What the pattern emphasizes

Intersecting bundles of fibrous tissue create a woven or whorled architecture.

Storiform is a pattern of organization; It is not a molecular diagnosis.

Storiform fibrous tissue in retroperitoneal fibrosis.

Slide 21 · Lymphocytes: Prominent chronic inflammation

Schematic — not a histology image

What the pattern emphasizes

Lymphocytes form a substantial inflammatory component.

They coexist with fibrosis rather than replacing it.

Pattern recognition requires examination of both stroma and infiltrate.

Slide 22 · Germinal centers may occur in the infiltrate

Schematic — not a histology image

What the pattern emphasizes

Lymphocytes often arranged with germinal centers.

Organized lymphoid aggregates support a chronic immune-inflammatory milieu.

Their presence alone does not identify a unique etiology.

Slide 23 · Plasma cells are frequent in the lesion

Schematic — not a histology image

What the pattern emphasizes

Plasma cells accompany lymphocytes within the fibrotic tissue.

Many cases contain IgG4-positive plasma cells.

Cell positivity must be interpreted together with tissue morphology.

Slide 24 · What does IgG4 positivity establish?

Supported inference

IgG4-positive plasma cells occur frequently in the lesion; An IgG4-related subset is recognized.

Unsupported shortcut

IgG4-positive cells alone are insufficient to prove that every lesion has IgG4-related disease.

Interpretation

Robbins provides no retroperitoneal quantitative staining threshold in this passage.

Slide 25 · Eosinophils complete the mixed infiltrate

Eosinophils are included among the microscopic inflammatory cells described.

They occur alongside lymphocytes and plasma cells in storiform fibrous tissue.

The composition reflects a mixed chronic inflammatory background.

Clinicopathologic implication

Do not substitute a single cell type for the broader composite histologic pattern.

Slide 26 · Integrated histopathologic profile

Component

Observed / expected finding

Interpretive role

Stroma

Storiform fibrosis

Provides the architectural pattern

Lymphoid cells

Prominent lymphocytes; sometimes germinal centers

Shows chronic immune-inflammatory component

Plasma cells

Common; often IgG4-positive

Supports possible IgG4 association

Eosinophils

May accompany the infiltrate

Additional component of the mixed inflammation

Composite patterns are more informative than any isolated feature.

Slide 27 · The histologic pattern does not establish every cause

Idiopathic, IgG4-associated and secondary conditions require etiologic interpretation.

Morphologic resemblance does not erase the need to consider malignancy or exposures.

Tissue findings and etiologic categories as related but distinct domains.

Clinicopathologic implication

An etiologic diagnosis requires correlation beyond descriptive fibrosis.

Slide 28 · IgG4-related disease: Broader tissue signature

Schematic causal sequence

1

Lymphocytes and plasma cells

2

IgG4-rich infiltrates

3

Fibrosis; May be storiform

4

Obliterative phlebitis

Interpretation

This is the textbook profile of systemic IgG4-RD; Individual lesions may not display every feature.

Slide 29 · Obliterative phlebitis in the systemic IgG4 pattern

Normal concept

A vein has a recognizable lumen and wall surrounded by tissue.

IgG4-related change

Inflammation and fibrosis may obliterate venous structures (obliterative phlebitis).

Interpretation

A characteristic systemic IgG4-RD feature—not claimed by the short retroperitoneal passage to occur in every case.

Slide 30 · Serum IgG4: Useful but not absolute

What Robbins says

Serum IgG4 is usually elevated in systemic IgG4-related disease.

What it does not say

A particular serum concentration by itself establishes or excludes retroperitoneal IgG4-RD.

Interpretation

No diagnostic cutoff, sensitivity or specificity is supplied in the source.

Slide 31 · Pathogenesis remains incompletely explained

The cause and pathogenetic mechanism of IgG4-related disease remain unclear.

Autoimmune reactions are suspected, but causative autoantigens are unidentified.

Production of IgG4 is a lesion hallmark, not proof of pathogenic action.

Clinicopathologic implication

Separate immune association from demonstrated antibody-mediated injury.

Slide 32 · IgG4 production and causality

Observation in Robbins

Inference allowed

Inference not established

IgG4-positive plasma cells

B-cell lineage participates in tissue response

IgG4 antibody itself drives fibrosis

Usually raised serum IgG4

May provide systemic context

A stand-alone diagnostic rule

Anti–B-cell therapy benefit

B cells have an important role

A known pathogenic autoantigen

The antibody’s role in generating fibrosis remains uncertain.

Slide 33 · Immune-cell involvement: Evidence and limits

Schematic causal sequence

1

B cells / plasma cells present

2

Antigen presentation to T cells is possible

3

Fibroinflammatory tissue injury

4

Fibrotic organ dysfunction

Interpretation

This pathway is a conceptual hypothesis, not a fully proven molecular cascade; Uncertainty.

Slide 34 · Clinical benefit from B-cell depletion

Benefit of anti–B-cell antibodies in systemic IgG4-related disease.

This supports a pathogenetic role for B cells, possibly through antigen presentation.

The passage does not prescribe this therapy for all retroperitoneal fibrosis.

Clinicopathologic implication

Evidence supporting a cell population is not equivalent to identifying a specific autoantibody-mediated mechanism.

Slide 35 · Normal urine drainage establishes the contrast

Conceptual urinary outflow anatomy

Patent ureteral drainage

Urine passes from renal collecting systems into ureters.

Unimpeded drainage prevents pressure accumulation in the collecting system.

An extrinsic lesion may interrupt this path along the ureter.

Slide 36 · Obstruction can vary across three axes

Axis

Examples described by Robbins

Why it matters

Tempo

Sudden versus insidious

Symptoms and adaptation can differ

Degree

Partial versus complete

Determines severity of impaired flow

Distribution

Unilateral versus bilateral

Changes the extent of renal risk

RPF is one of several extrinsic causes; It does not impose one uniform pattern of obstruction.

Slide 37 · Where RPF fits among obstructive lesions

Intrinsic categories

Calculi, strictures, intraluminal tumors, blood clots; Neurogenic abnormalities affect drainage.

Extrinsic categories

Pregnancy, periureteral inflammation including RPF, endometriosis and surrounding tumors.

Interpretation

The table classifies mechanisms of urinary outflow interruption, not histologic disease subtypes.

Slide 38 · Intrinsic causes: Contrasting mechanisms

Intrinsic entity

Typical obstructive mechanism

Calculus

A stone lodged within the ureteral lumen

Stricture

Fixed narrowing due to congenital or acquired ureteral change

Ureteral neoplasm

Tumor involving the ureter

Blood clot

Intraluminal blockage associated with substantial hematuria

RPF is external to the ureter and must not be confused with an intraluminal calculus.

Slide 39 · Extrinsic causes: Contextual differential

Extrinsic lesion

Pathologic context

Periureteral inflammation

Includes sclerosing retroperitoneal fibrosis

Endometriosis

Pelvic lesions and associated scarring

Pregnancy

Smooth muscle relaxation or pressure from enlarged fundus

Adjacent malignancy

Pelvic / retroperitoneal tumors may compress ureters

Different external causes can have similar downstream urinary consequences.

Slide 40 · Laterality and level of obstruction

Schematic causal sequence

1

Proximal / local ureteral process

2

Often unilateral obstruction

3

Distal widespread or outlet process

4

May produce bilateral obstruction

Interpretation

This is a typical pattern described in the chapter, not an absolute rule for every cause.

Slide 41 · How hydronephrosis develops

Schematic causal sequence

1

Impaired urinary outflow

2

Upstream collecting-system pressure

3

Dilation of pelvis and calyces

4

Progressive parenchymal atrophy

Interpretation

Hydronephrosis denotes collecting-system dilation with injury from urinary obstruction.

Slide 42 · Pressure transmission links obstruction to injury

Schematic causal sequence

1

Pelvic pressure rises

2

Pressure transmitted into renal parenchyma

3

Medullary vascular compression

4

Persistent functional disturbance

Interpretation

The kidney response explains why an extrarenal ureteral lesion may cause intrarenal functional damage.

Slide 43 · Early functional injury is predominantly tubular

Schematic causal sequence

1

Obstruction alters medullary blood flow

2

Tubular concentrating capacity falls

3

Polyuria / nocturia may appear

4

GFR decline emerges later

Interpretation

The order of changes matters: Concentrating defects can precede a substantial filtration decline.

Slide 44 · The medullary circulation is vulnerable

Increased pressure compresses intrarenal vessels, particularly in the medulla.

Reduced inner medullary blood flow initially produces potentially reversible disturbances.

Prolonged damage can impair concentrating function.

Clinicopathologic implication

The hemodynamic consequences are mediated through obstruction, not a direct renal lesion from the fibrosis.

Slide 45 · Long-standing obstruction produces scarring

Schematic causal sequence

1

Persistent urinary blockage

2

Interstitial inflammatory reaction

3

Interstitial fibrosis and tubular atrophy

4

Progressive loss of renal parenchyma

Interpretation

Relief of obstruction is important before structural injury becomes advanced.

Slide 46 · Renal morphology evolves with duration

Earlier obstruction

Long-standing obstruction

Pelvic and calyceal dilation

Marked dilation with parenchymal thinning

Interstitial inflammation may occur

Diffuse interstitial fibrosis develops

Potentially reversible functional changes

Cortical tubular atrophy and loss of pyramidal architecture

Morphology reflects severity and duration; These are renal consequences, not the primary retroperitoneal lesion.

Slide 47 · Hydronephrosis is the downstream morphology

Conceptual urinary outflow anatomy

Fibrosis surrounding ureters

Collecting-system dilation is an effect of urinary obstruction.

Progressive atrophy reflects sustained upstream pressure and injury.

The original fibrosis may be outside the kidney, along the ureter.

Slide 48 · Obstruction increases additional renal risks

Schematic causal sequence

1

Urinary stasis / impaired drainage

2

Increased susceptibility to infection

3

Potential stone formation

4

Further renal damage if uncorrected

Interpretation

Robbins explicitly links urinary obstruction with infection and stone susceptibility.

Slide 49 · Unilateral obstruction can be silent

One unaffected kidney may preserve adequate global renal function.

Complete or partial unilateral hydronephrosis may remain unrecognized for a prolonged period.

The abnormality can be found incidentally on imaging.

Clinicopathologic implication

A normal global filtration assessment does not necessarily rule out unilateral obstruction.

Slide 50 · Bilateral partial obstruction may present functionally

Loss of concentrating ability may occur early.

Polyuria and nocturia are characteristic initial manifestations.

Tubular acidosis, salt wasting and chronic scarring can occur with progression.

Clinicopathologic implication

The symptoms follow tubulointerstitial dysfunction rather than solely a fall in GFR.

Slide 51 · Complete bilateral obstruction is an emergency pattern

Rapid, complete bilateral obstruction can cause oliguria or anuria.

Persistently blocked outflow jeopardizes renal survival.

RPF can produce bilateral hydronephrosis; Severity must be assessed in each patient.

Clinical danger

No claim is made that every retroperitoneal fibrotic lesion causes complete bilateral obstruction.

Slide 52 · Pain and silence in obstructive uropathy

Possible symptomatic pattern

Acute distention of the collecting system or renal capsule may produce pain.

Possible silent pattern

Insidious or unilateral obstruction may remain clinically inconspicuous until imaging.

Interpretation

Presentation depends on both tempo and distribution of obstruction.

Slide 53 · Imaging starts with the effect of obstruction

Schematic causal sequence

1

Suspect impaired urinary drainage

2

Ultrasonography may detect hydronephrosis

3

Characterize the site / cause

4

Interpret alongside etiologic context

Interpretation

Robbins specifically describes ultrasonography as a useful noninvasive modality for obstructive uropathy; This is not a detailed imaging guideline.

Slide 54 · Integrated pathologic interpretation

Information domain

What it contributes

Anatomic

Fibroinflammatory tissue around ureteral/retroperitoneal structures

Microscopic

Storiform fibrosis with mixed lymphoplasmacytic inflammation

Etiologic context

Idiopathic, IgG4-associated or recognized secondary conditions

Functional

Hydroureter, hydronephrosis and renal dysfunction from obstruction

The disease is best understood across tissue, cause and organ-function levels.

Slide 55 · Inflammatory fibrosis versus tumor-associated obstruction

Feature

RPF framework

Malignancy-associated framework

Tissue explanation

Primary fibroinflammatory proliferation

Tumor may directly obstruct or accompany fibrosis

Histology

Storiform fibrous tissue; chronic inflammatory cells

Evidence of a neoplastic process would change interpretation

Etiologic action

Evaluate IgG4 spectrum and exposures

Assess plausible underlying lymphoma or carcinoma

This is a conceptual distinction, not a source-derived numerical diagnostic classifier.

Slide 56 · Reason through a suspected case

Schematic causal sequence

1

Identify obstruction and laterality

2

Recognize an extrinsic retroperitoneal process

3

Integrate tissue pattern if available

4

Consider idiopathic, IgG4 and secondary associations

Interpretation

Priorities are conceptual and based on Robbins’ pathology account; Local clinical protocols determine the actual investigation sequence.

Slide 57 · Corticosteroids are the initial treatment

Corticosteroids as the initial treatment of retroperitoneal fibrosis.

This approach addresses the inflammatory component of the lesion.

Stopping progression of obstruction is a separate functional priority.

Clinicopathologic implication

A treatment response does not itself specify the complete etiology or guarantee long-term urinary patency.

Slide 58 · Disease may become resistant to corticosteroids

Many patients eventually become resistant to steroid treatment.

Persisting fibrosis may maintain urinary outflow obstruction.

Anatomic intervention may therefore be required even when inflammation was treated.

Clinicopathologic implication

Anti-inflammatory treatment and mechanical relief of obstruction address different components of the problem.

Slide 59 · Restoring urinary flow: Two interventions

Ureteral stenting

Maintains a drainage route through the ureter when fibrotic encasement threatens its patency.

Ureterolysis

Surgically frees the ureter from surrounding fibrous tissue; Termed surgical extrication.

Interpretation

The source names both options but does not prescribe patient-specific indications or procedural timing.

Slide 60 · Treatment response should be interpreted narrowly

Fibroinflammatory lesions may be steroid responsive without proving a single underlying mechanism.

IgG4-related disease can show benefit from B-cell–targeted treatment in the broader systemic setting.

Renal function and urinary drainage require assessment regardless of immunologic attribution.

Clinicopathologic implication

Do not extrapolate systemic IgG4-RD efficacy directly into an unqualified RPF treatment recommendation.

Slide 61 · Case 1 — pathology-pattern recognition

Hypothetical teaching vignette

A middle-aged patient has bilateral hydroureteronephrosis and a retroperitoneal fibrotic lesion. Tissue contains storiform collagen, abundant lymphocytes, plasma cells and eosinophils; Many plasma cells stain for IgG4.

Interpretation task

What does the tissue pattern support, and what cannot it prove alone?

Slide 62 · Case 1 — interpretation

Supported

The specimen fits the fibroinflammatory morphology described for RPF, with features compatible with an IgG4-associated subset.

Not established

IgG4 immunostaining alone does not establish every diagnostic or etiologic requirement for systemic IgG4-related disease.

Interpretation

Assess the morphologic pattern together with clinical and possible multisystem findings.

Slide 63 · Case 2 — reconsidering the cause

Hypothetical teaching vignette

An older adult has ureteral obstruction with retroperitoneal fibrotic change. A clinical history identifies a urinary tract carcinoma.

Interpretation task

Which etiologic category must remain under consideration?

Slide 64 · Case 2 — interpretation

Correct concern

Malignancy-associated fibrosis or direct neoplastic obstruction must remain in the differential.

Incorrect shortcut

Labeling the process idiopathic merely because dense fibrosis is visible.

Interpretation

The coexistence of malignancy alters etiologic reasoning; It does not establish the exact mechanism without more evidence.

Slide 65 · Case 3 — physiology before filtration failure

Hypothetical teaching vignette

A patient with progressive bilateral partial ureteral obstruction develops nocturia and difficulty concentrating urine; Serum filtration measures have not yet fallen markedly.

Interpretation task

How can this sequence occur?

Slide 66 · Case 3 — pathophysiologic answer

Early event

Urinary back-pressure and medullary hemodynamic disturbance impair tubular concentrating function.

Later event

Prolonged obstruction may lead to tubulointerstitial fibrosis, atrophy and decline in GFR.

Interpretation

This is a renal consequence of obstruction, independent of whether the initiating lesion is RPF or another obstructive cause.

Slide 67 · Final synthesis: Six durable anchors

Question

Core answer

What is it?

Rare retroperitoneal fibroinflammatory encasing process

What is the danger?

Extrinsic ureteral obstruction and hydronephrosis

What causes it?

Often idiopathic; IgG4 subset; drug, inflammatory or malignant associations

What does tissue show?

Storiform fibrosis with lymphocytes, plasma cells and eosinophils

How does renal injury evolve?

Early tubular dysfunction; later atrophy and reduced function

How is it approached?

Corticosteroids initially; stenting or ureterolysis may be needed

Slide 68 · References

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026).

Primary section: Sclerosing Retroperitoneal Fibrosis.

Related section: IgG4-Related Disease.

Related section: Urinary Tract Obstruction (Obstructive Uropathy).

Also consulted: ureteral obstruction, inflammatory aortic disease, and sclerosing retroperitonitis.